Skip to content
← Full study record

NCT00481247 · ADVERSE EVENTS

Adverse events

A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia · Source last updated 2017-02-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
Randomization to end of study (December 2015)
Other-event reporting threshold
5%

Study initiated: September 2007; End of Study: December 2015

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Dasatinib

Tablets, oral, dasatinib 100 mg once daily (QD)

90 / 258216 / 258Not reported / Not reported
Imatinib

Tablets, oral, imatinib 400 mg once daily (QD)

70 / 258231 / 258Not reported / Not reported

Group identifiers: EG000: Dasatinib · EG001: Imatinib

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    ANAEMIA
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    BICYTOPENIA
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    BONE MARROW FAILURE
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      258
    term
    FEBRILE NEUTROPENIA
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    NEUTROPENIA
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    PANCYTOPENIA
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      4
      num At Risk
      258
    term
    THROMBOCYTOPENIA
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA (18.1)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    LEUKOCYTOSIS
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA (18.1)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    THROMBOCYTOSIS
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    ACUTE MYOCARDIAL INFARCTION
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    ANGINA UNSTABLE
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    CARDIAC ARREST

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      38
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      31
      num At Risk
      258
    term
    ANAEMIA
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      21
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      28
      num At Risk
      258
    term
    LEUKOPENIA
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      60
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      49
      num At Risk
      258
    term
    NEUTROPENIA
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      59
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      48
      num At Risk
      258
    term
    THROMBOCYTOPENIA
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      7
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      40
      num At Risk
      258
    term
    EYELID OEDEMA
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    source Vocabulary
    MedDRA (18.1)
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      20
      num At Risk
      258
    term
    PERIORBITAL OEDEMA
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      36
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      28
      num At Risk
      258
    term
    ABDOMINAL PAIN
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      22
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      18
      num At Risk
      258
    term
    ABDOMINAL PAIN UPPER
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      21
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      7
      num At Risk
      258
    term
    CONSTIPATION
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      99
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      89
      num At Risk
      258
    term
    DIARRHOEA
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      17
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      22
      num At Risk
      258
    term
    DYSPEPSIA
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      23
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      18
      num At Risk
      258
    term
    GASTRITIS
Complete source fields
description
Study initiated: September 2007; End of Study: December 2015
event Groups
  1. description
    Tablets, oral, dasatinib 100 mg once daily (QD)
    id
    EG000
    other Num Affected
    216
    other Num At Risk
    258
    serious Num Affected
    90
    serious Num At Risk
    258
    title
    Dasatinib
  2. description
    Tablets, oral, imatinib 400 mg once daily (QD)
    id
    EG001
    other Num Affected
    231
    other Num At Risk
    258
    serious Num Affected
    70
    serious Num At Risk
    258
    title
    Imatinib
frequency Threshold
5
other Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      38
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      31
      num At Risk
      258
    term
    ANAEMIA
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      21
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      28
      num At Risk
      258
    term
    LEUKOPENIA
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      60
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      49
      num At Risk
      258
    term
    NEUTROPENIA
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      59
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      48
      num At Risk
      258
    term
    THROMBOCYTOPENIA
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      7
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      40
      num At Risk
      258
    term
    EYELID OEDEMA
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    source Vocabulary
    MedDRA (18.1)
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      20
      num At Risk
      258
    term
    PERIORBITAL OEDEMA
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      36
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      28
      num At Risk
      258
    term
    ABDOMINAL PAIN
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      22
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      18
      num At Risk
      258
    term
    ABDOMINAL PAIN UPPER
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      21
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      7
      num At Risk
      258
    term
    CONSTIPATION
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      99
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      89
      num At Risk
      258
    term
    DIARRHOEA
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      17
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      22
      num At Risk
      258
    term
    DYSPEPSIA
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      23
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      18
      num At Risk
      258
    term
    GASTRITIS
serious Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    ANAEMIA
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    BICYTOPENIA
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    BONE MARROW FAILURE
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      3
      num At Risk
      258
    term
    FEBRILE NEUTROPENIA
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    NEUTROPENIA
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    PANCYTOPENIA
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      4
      num At Risk
      258
    term
    THROMBOCYTOPENIA
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA (18.1)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    LEUKOCYTOSIS
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    MedDRA (18.1)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    THROMBOCYTOSIS
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      258
    term
    ACUTE MYOCARDIAL INFARCTION
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    ANGINA UNSTABLE
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    MedDRA 12.1
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      258
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      258
    term
    CARDIAC ARREST
time Frame
Randomization to end of study (December 2015)

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice